(IBHF) iShares iBonds 2026 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E5289

High-Yield Bonds, 2026 Maturity

Description: IBHF iShares iBonds 2026 Term

IBHF is a U.S.-domiciled exchange‑traded fund that follows a target‑maturity strategy, aiming to hold a portfolio of high‑yield corporate bonds that will be fully liquidated around 2026. Its focus on high‑yield income positions it as a fixed‑income vehicle for investors seeking elevated yield relative to investment‑grade alternatives.

The fund trades at $23.43, essentially at its 52‑week high, with short‑term price momentum indicated by a 20‑day SMA of $23.23 and a 50‑day SMA of $23.10. The 200‑day SMA sits at $22.63, confirming an upward bias over the longer term. Daily volatility is low, with an ATR of $0.04 (≈0.17%). A beta of 0.42 signals markedly lower correlation to the S&P 500, while average daily volume of roughly 247 k shares provides sufficient liquidity for most institutional and retail participants.

Key risk drivers stem from credit quality and interest‑rate exposure. The portfolio is weighted toward BB and B‑rated issuers, making default risk the primary concern. High‑yield spreads are highly sensitive to macroeconomic conditions: tightening monetary policy or a slowdown in corporate earnings tends to widen spreads and depress total return, whereas a robust economy compresses spreads and boosts income. The fund’s effective duration is short (≈2 years), limiting interest‑rate risk but still exposing it to the Fed’s policy trajectory.

Fundamentals include $900 million in assets under management and an expense ratio near 0.25 %. The distribution yield typically ranges between 6 % and 7 % on a 30‑day SEC yield basis, reflecting the high‑yield coupon environment. Turnover is modest, preserving the intended credit composition and reducing transaction costs. The weighted‑average maturity aligns with the 2026 target, ensuring a predictable wind‑down schedule and capital return at maturity.

Performance outlook hinges on the trajectory of high‑yield spreads and corporate default rates. A continued decline in spreads, driven by a stable macro environment and resilient corporate earnings, would sustain the fund’s income generation and price appreciation. Conversely, any escalation in credit stress or aggressive rate hikes would increase spread volatility and pressure both yield and NAV. Investors should monitor Fed policy, GDP growth, and high‑yield index spread movements as primary leading indicators.

IBHF ETF Overview

Market Cap in USD 900m
Category Target Maturity
TER 0.35%
IPO / Inception 2020-11-10

IBHF ETF Ratings

Growth Rating 65.0%
Fundamental -
Dividend Rating 80.0%
Return 12m vs S&P 500 -7.77%
Analyst Rating -

IBHF Dividends

Dividend Yield 12m 6.84%
Yield on Cost 5y 8.48%
Annual Growth 5y 60.45%
Payout Consistency 82.3%
Payout Ratio %

IBHF Growth Ratios

Growth Correlation 3m 99.1%
Growth Correlation 12m 96.8%
Growth Correlation 5y 73.5%
CAGR 5y 5.03%
CAGR/Max DD 5y 0.45
Sharpe Ratio 12m 2.06
Alpha 2.24
Beta 0.122
Volatility 2.47%
Current Volume 299.6k
Average Volume 20d 271.6k
Stop Loss 22.6 (-3.4%)
Signal 0.00

What is the price of IBHF shares?

As of August 30, 2025, the stock is trading at USD 23.40 with a total of 299,606 shares traded.
Over the past week, the price has changed by +0.41%, over one month by +1.13%, over three months by +2.51% and over the past year by +7.88%.

Is iShares iBonds 2026 Term a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds 2026 Term (BATS:IBHF) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.01 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHF is around 24.61 USD . This means that IBHF is currently overvalued and has a potential downside of 5.17%.

Is IBHF a buy, sell or hold?

iShares iBonds 2026 Term has no consensus analysts rating.

What are the forecasts/targets for the IBHF price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.9 15.1%

Last update: 2025-08-23 04:40

IBHF Fundamental Data Overview

Market Cap USD = 900.3m (900.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.42
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 900.3m USD (900.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 900.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 900.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(900.3m)/V(0.0) * Re(6.46%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.46% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHF ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle